KPL-387 not checked

Kiniksa Pharmaceuticals International, plc

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2/3 trial completes
Trials
2 active
2 in total · 1 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Pericarditis (2 trials), Recurrent Pericarditis (2 trials), Pericarditis Acute, Heart Diseases
Main trialPhase 2/3
“This study is being done to demonstrate whether KPL-387 is an effective and safe treatment for recurrent pericarditis.”In the company’s words, NCT07010159 on ClinicalTrials.gov

Other drugs for Pericarditis

All 4 drugs for Pericarditis

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 2/3Recruiting 31 Dec 2027 Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
Phase 2Recruiting 31 Dec 2027 Transition to KPL-387 Monotherapy Dosing & Administration Study
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow KPL-387

Following is part of Solo: you see every change to KPL-387 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in